<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The expression of transforming growth factor beta (TGF-β) and Smad3 regulates extracellular matrix homeostasis and <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The expression of Smad3 depends on signaling by <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> (<z:chebi fb="0" ids="48432">AngII</z:chebi>) receptor pathways through TGF-β receptor-dependent and -independent pathways </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: To determine the expression of <z:chebi fb="0" ids="48432">AngII</z:chebi> type 1 (AT1R) and type 2 receptors (AT2R), TGF-β, and Smad3 in thoracic <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo>, we performed immunohistochemistry testing on tissue and cultured cells derived from subjects with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) and <z:hpo ids='HP_0001647'>bicuspid aortic valve</z:hpo> (<z:mp ids='MP_0010484'>BAV</z:mp>) malformation and from <z:mpath ids='MPATH_458'>normal</z:mpath> aortas of subjects who were organ donors </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and <z:mp ids='MP_0010484'>BAV</z:mp> <z:hpo ids='HP_0002617'>aneurysm</z:hpo> tissue showed enhanced accumulation of TGF-β and Smad3 in vascular smooth muscle cells (VSMCs) and in inflammatory cells in the subintimal layer and tunica media </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:mpath ids='MPATH_458'>normal</z:mpath> aortic wall exhibited minimal TGF-β and Smad3 staining </plain></SENT>
<SENT sid="5" pm="."><plain>Cultured VSMCs from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and <z:mp ids='MP_0010484'>BAV</z:mp> samples showed nuclear Smad3 and strong cytoplasmic TGF-β expression in the cytoplasmic vesicles </plain></SENT>
<SENT sid="6" pm="."><plain>In control cells, Smad3 was located mainly in the cytoplasm, and weak cytoplasmic TGF-β was distributed with a pattern similar to that of the <z:hpo ids='HP_0002617'>aneurysm</z:hpo>-derived cells </plain></SENT>
<SENT sid="7" pm="."><plain>Compared to <z:mpath ids='MPATH_458'>normal</z:mpath> aorta cells, AT1R and AT2R expression was increased in both <z:hpo ids='HP_0002617'>aneurysm</z:hpo> types </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment of cultured VSMCs with the AT1R <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:chebi fb="0" ids="6541">losartan</z:chebi> caused both reduced TGF-β vesicle localization and nuclear expression of Smad3 </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Increased TGF-β and Smad3 expression in <z:hpo ids='HP_0002617'>aneurysm</z:hpo> tissue and cultured VSMCs is consistent with aberrant TGF-β expression and the activation of Smad3 signaling </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="6541">Losartan</z:chebi>-mediated reduction in TGF-β expression and the cytoplasmic localization of Smad3 support a role for AT1R antagonism in the inhibition of <z:hpo ids='HP_0002617'>aneurysm</z:hpo> progression </plain></SENT>
</text></document>